Inmune Bio Files 8-K Report
Ticker: INMB · Form: 8-K · Filed: May 5, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: INMB
TL;DR
INMB filed an 8-K, check for updates on financials/operations.
AI Summary
On May 5, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and business operations. Specific details regarding the nature of these events or financial statements are not elaborated in the provided text.
Why It Matters
This 8-K filing signals to investors that Inmune Bio, Inc. has made a significant disclosure to the SEC, potentially impacting the company's stock value.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report, which typically contains routine disclosures and does not inherently signal high risk without further context.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- 0001711754 (company) — Central Index Key
- 475205835 (company) — EIN
- May 5, 2025 (date) — Date of earliest event reported
FAQ
What specific "Other Events" are being reported by Inmune Bio, Inc. in this 8-K filing?
The provided text for the 8-K filing lists "Other Events" as an item, but does not specify the nature of these events.
What is the significance of the "Financial Statements and Exhibits" being included in this filing?
The inclusion of "Financial Statements and Exhibits" suggests that Inmune Bio, Inc. is providing updated financial information or related documentation to the SEC.
When was this 8-K report filed by Inmune Bio, Inc.?
The filing was made on May 5, 2025, and the date of the earliest event reported is also May 5, 2025.
What is Inmune Bio, Inc.'s Central Index Key (CIK) and IRS Employer Identification Number (EIN)?
Inmune Bio, Inc.'s CIK is 0001711754 and its EIN is 475205835.
Where is Inmune Bio, Inc.'s principal executive office located?
Inmune Bio, Inc.'s principal executive offices are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding Inmune Bio, Inc. (INMB).